Jean-Pierre Iliou

Title: The Innovations of Jean-Pierre Iliou

Introduction

Jean-Pierre Iliou is a notable inventor based in Puteaux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. With a total of four patents to his name, Iliou's work has the potential to impact the treatment of serious health issues.

Latest Patents

Iliou's latest patents include innovative compounds such as substituted sulfonamides. These compounds are N-(2,3,4-trimethoxybenzyl)piperazines N'-substituted by a radical containing a sulfonamide group, which are useful for treating myocardial ischaemic pathologies, cerebral vascular accidents, and manifestations of deficiency associated with chronic cerebral circulatory disorders. One of the disclosed compounds is N-benzyl-N-{3,3-dimethyl-4-[4-(2,3,4-trimethoxybenzyl)piperazin-1-yl]butyl}-(isoquinolin-5-yl)sulfonamide and its fumarate. Additionally, he has developed trimetazidine compounds, which are substituted trimetazidine useful for the treatment of ischaemic pathologies and peripheral vascular pathology. A notable compound in this category is 4-(2,3,4-trimethoxybenzyl)-1-[3-(4-hydroxy-2,3,5-trimethylphenoxy)propyl]piperazine.

Career Highlights

Jean-Pierre Iliou is associated with Adir Et Compagnie, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to improving health outcomes through scientific research and development.

Collaborations

Iliou has collaborated with notable colleagues such as Jean-Paul Vilaine and Gilbert Regnier. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Jean-Pierre Iliou's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to addressing critical health issues. His work continues to pave the way for advancements in medical treatments.